跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,586 条关于
“N-nitrosamine impurities”
全部
6,586
临床试验
2,476
药物
2,142
机构
82
资讯
1,886
2年前
Aptar's N-Sorb Nitrosamine Mitigation Solution Accepted into FDA's Emerging Technology Program
10个月前
Piramal Pharma Solutions Achieves Full Regulatory Compliance for Nitrosamine Impurities
3个月前
Towa Pharmaceutical Recalls Duloxetine Over Nitrosamine Impurity; FDA Classifies as Class II Recall
去年
FDA Tightens Nitrosamine Testing Requirements with New Guidelines Taking Effect This August
3个月前
FDA Issues Class II Recall of Duloxetine Over Nitrosamine Impurity Risk
11个月前
FDA Issues Class II Recall for Over 580,000 Bottles of Prazosin Blood Pressure Medication Due to Cancer-Causing Impurities
去年
FDA Recalls 7,107 Bottles of Generic Duloxetine Over Carcinogenic Chemical Contamination
去年
Fortrea and Emery Pharma Partner to Enable FDA-Compliant Rifampin Use in Drug-Drug Interaction Studies
9个月前
EpiVax and FDA Scientists Identify Immunogenicity Risks in Generic Teriparatide Impurities
12个月前
FDA Unveils Eight Science Priorities for 2026 Generic Drug Program, Emphasizing AI Integration and Complex Product Development
第 1 页,共 189 页
上一页
下一页